JPMorgan Chase & Co’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.8K | Sell |
|
|||||
|
2025
Q1 | $56K | Buy |
|
|||||
|
2024
Q4 | $73.7K | Sell |
|
|||||
|
2024
Q3 | $248K | Buy |
|
|||||
|
2024
Q2 | $94.3K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $5.93M | Sell |
|
|||||
|
2023
Q1 | $6.03M | Buy |
|
|||||
|
2022
Q4 | $11.5M | Sell |
|
|||||
|
2022
Q3 | $16.5M | Sell |
|
|||||
|
2022
Q2 | $27.5M | Buy |
|
|||||
|
2022
Q1 | $50.2M | Buy |
|
|||||
|
2021
Q4 | $64.5M | Sell |
|
|||||
|
2021
Q3 | $88.8M | Buy |
|
|||||
|
2021
Q2 | $77.9M | Buy |
|
|||||
|
2021
Q1 | $76.7M | Buy |
|
|||||
|
2020
Q4 | $95.6M | Buy |
|
|||||
|
2020
Q3 | $68.6M | Buy |
|
|||||
|
2020
Q2 | $53.5M | Buy |
|